Overexpression of connexin 43 using a retroviral vector improves electrical coupling of skeletal myoblasts with cardiac myocytes in vitro

BMC Cardiovascular Disorders

Volumn 6, Issue , 2006, Pages

  Tolmachov, Oleg ^a   Ma, Yu Ling ^b   Themis, Michael ^a   Patel, Pravina ^b   Spohr, Hilmar ^b   MacLeod, Kenneth T ^c   Ullrich, Nina D ^c   Kienast, Yvonne ^a   Coutelle, Charles ^a   Peters, Nicholas S ^b  

^a Faculty of Life Sciences   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CONNEXIN 43; FLUORESCENT DYE; RETROVIRUS VECTOR;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL INTERACTION; CELL TRANSFER; COCULTURE; CONTROLLED STUDY; FLOW CYTOMETRY; GAP JUNCTION; GENETIC TRANSDUCTION; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART TRANSPLANTATION; IN VITRO STUDY; MARKER GENE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; STATISTICAL SIGNIFICANCE; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; WESTERN BLOTTING;

ANIMALS; CELL LINE; CONNEXIN 43; ELECTROMYOGRAPHY; GENETIC VECTORS; MALE; MYOBLASTS, SKELETAL; MYOCYTES, CARDIAC; PLASMIDS; RATS; RATS, WISTAR; RETROVIRIDAE; TRANSFECTION;

EID: 33746104916     PISSN: 14712261     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-6-25     Document Type: Article

References (33)

1. Anversa P, Nadal-Ginard B: Myocyte renewal and ventricular remodelling. Nature 2002, 415:240-243.
2. Zannad F, Briancon S, Juilliere Y, Mertes PM, Villemot JP, Alla F, Virion JM: Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine. J Am Coll Cardiol 1999, 33:734-742.
3. Keon WJ: Heart transplantation in perspective. J Card Surg 1999, 14:147-151.
4. Muller-Ehmsen J, Kedes LH, Schwinger RH, Kloner RA: Cellular cardiomyoplasty - a novel approach to treat heart disease. Congest Heart Fail 2002, 8:220-227.
5. Scorsin M, Hagege A, Vilquin JT, Fiszman M, Marotte F, Samuel JL, Rappaport L, Schwartz K, Menasche P: Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. 2. J Thorac Cardiovasc Surg 2000, 119:1169-1175.
6. Ott HC, Bonaros N, Marksteiner R, Wolf D, Margreiter E, Schachner T, Laufer G, Hering S: Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats. Eur J Cardiothorac Surg 2004, 25:627-634.
7. Hutcheson KA, Atkins BZ, Hueman MT, Hopkins MB, Glower DD, Taylor DA: Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant 2000, 9:359-368.
8. Jain M, DerSimonian H, Brenner DA, Ngoy S, Teller P, Edge AS, Zawadzka A, Wetzel K, Sawyer DB, Colucci WS, Apstein CS, Liao R: Cell therapy attenuates deleterious ventricular remodelling and improves cardiac performance after myocardial infarction. Circulation 2001, 103:1920-1927.
9. Reinecke H, MacDonald GH, Hauschka SD, Murry CE: Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J Cell Biol 2000, 149:731-740.
10. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Alcher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOP-CARE-AMI). Circulation 2002, 106:3009-3017.
11. Menasche P, Hagege AA, Scorsin M, Pouzet B, Desnos M, Duboc D, Schwartz K, Vilquin JT, Marolleau JP: Myoblast transplantation for heart failure. Lancet 2001, 357:279-280.
12. Abraham MR, Henrikson CA, Tung L, Chang MG, Aon M, Xue T, Li RA, O'Rourke B, Marban E: Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circulation Research 2005, 97:159-167.
13. Schmalbruch H: Skeletal muscle fibers of newborn rats are coupled by gap junctions. Dev Biol 1982, 91:485-490.
14. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY; 1989.
15. Fishman GI, Spray DC, Leinwand LA: Molecular characterization and functional expression of the human cardiac gap junction channel. J Cell Biol 1990, 111:589-598.
16. Kinsella TM, Nolan GP: Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther 1996, 7:1405-1413.
17. Slingsby JH, Baban D, Sutton J, Esapa M, Price T, Kingsman SM, Kingsman AJ, Slade A: Analysis of 4070A envelope levels in retroviral preparations and effect on target cell transduction efficiency. Hum Gene Ther 2000, 11:1439-1451.
18. Blanco-Bose WE, Yao CC, Kramer RH, Blau HM: Purification of mouse primary myoblasts based on alpha 7 integrin expression. Exp Cell Res 2001, 265:212-220.
19. Tonks A, Tonks AJ, Pearn L, Mohamad Z, Burnett AK, Darley RL: Optimized retroviral transduction protocol which preserves the primitive subpopulation of human hematopoietic cells. Biotechnol Prog 2005, 21:953-958.
20. Themis M, Forbes SJ, Chan L, Cooper RG, Etheridge CJ, Miller AD, Hodgson HJ, Coutelle C: Enhanced in vitro and in vivo gene delivery using cationic agent complexed retrovirus vectors. Gene Ther 1998, 5:1180-1186.
21. Menasche P: Skeletal myoblast for cell therapy. Coron Artery Dis 2005, 16:105-110.
22. Reinecke H, Poppa V, Murry CE: Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002, 34:241-249.
23. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, Charpak S: Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A 2003, 100:7808-7811.
24. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, Bel A, Sarateanu S, Scorsin M, Schwartz K, Bruneval P, Benbunan M, Marolleau JP, Duboc D: Autologous skeletal myoblast transplantation for severe postinfarction left vetricular dysfunction. J Am Coll Cardiol 2003, 41:1078-1083.
25. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, Maat AP, Serruys PW: Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 2003, 42:2063-2069.
26. el Oakley RM, Brand NJ, Burton PB, McMullen MC, Adams GB, Poznansky MC, Barton PJ, Yacoub MH: Efficiency of a high-titer retroviral vector for gene transfer into skeletal myoblasts. J Thorac Cardiovasc Surg 1998, 115:1-8.
27. Loser P, Jennings GS, Strauss M, Sandig V: Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB. J Virol 1998, 72:180-190.
28. Federico M, Bona R, D'Aloja P, Baiocchi M, Pugliese K, Nappi F, Chelucci C, Mavilio F, Verani P: Anti-HIV viral interference induced by retroviral vectors expressing a nonproducer HIV-I variant. Acta Haematol 1996, 95:199-203.
29. Nethe M, Berkhout B, van der Kuyl AC: Retroviral superinfection resistance. Retrovirology 2005, 2:52.
30. Beer C, Buhr P, Hahn H, Laubner D, Wirth M: Gene expression analysis of murine cells producing amphotropic mouse leukaemia virus at a cultivation temperature of 32 and 37 degrees C. J Gen Virol 2003, 84:1677-1686.
31. Hughes C, Galea-Lauri J, Farzaneh F, Darling D: Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors. Mol Ther 2001, 3:623-630.
32. Fresnay S, Chalmers DE, Ferrand C, Colombain C, Newton I, Yerly-Motta V, Lienard A, Darodes de Tailly P, Herve P, Tiberghien P, Saas P: Polybrene and interleukin-4: two opposing factors for retroviral transduction of bone-marrow-derived dendritic cells. J Gene Med 2002, 4:601-612.
33. Reinecke H, Minami E, Virag JI, Murry CE: Gene transfer of connexin43 into skeletal muscle. Hum Gene Ther 2004, 15:627-636.